Atlas Venture Opportunity Fund I, L.P. Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

DAWN Quotes by TradingView

Atlas Venture Opportunity Fund I, L.P. is > 10% Shareholder of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 793,116 shares of DAWN, which is worth approximately $12.2 Million. The most recent transaction as insider was on Jul 01, 2022, when has been sold 198,280 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 793K
0% 3M change
0% 12M change
Total Value Held $12.2 Million

Atlas Venture Opportunity Fund I, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2022
SELL
Other acquisition or disposition
-
198,280 Reduced 20.0%
793,116 Common Stock

Also insider at

DYN
Dyne Therapeutics, Inc. Healthcare
AVO

Atlas Venture Opportunity Fund I, L.P.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DAWN